Dai Kun, Zhang Lili, Xia Yu, Sun Fuqiang, Ren Zhe, Lu Gengchen, Ma Ruimin, Cheng Bin
College of Acupuncture-Moxibustion and Tuina, Shandong University of TCM, Jinan 250013, China.
Department of Ultrasound, Central Hospital Affiliated to Shandong First Medical University.
Zhongguo Zhen Jiu. 2025 Jun 12;45(6):723-727. doi: 10.13703/j.0255-2930.20241107-k0003. Epub 2025 Mar 7.
To observe the clinical efficacy of acupuncture based on the "head " theory combined with endovascular intervention in the treatment of ischemic stroke (IS).
Sixty-six IS patients were randomly divided into an experimental group (33 cases, 3 cases dropped out) and a control group (33 cases, 3 cases dropped out). The control group received endovascular intervention. On the basis of the treatment in the control group, the experimental group received acupuncture based on the "head " theory starting from the second day after surgery, Baihui (GV20) and bilateral Fengchi (GB20), Tianzhu (BL10), etc. were selected, once a day, 6 times a week for 2 weeks. Before and after treatment, the scores of National Institutes of Health stroke scale (NIHSS), modified Barthel index (MBI) and modified Rankin scale (mRS) were observed in the two groups, the clinical efficacy and safety were evaluated.
After treatment, the NIHSS and mRS scores were decreased compared with those before treatment in both groups (<0.01), the NIHSS and mRS scores in the experimental group were lower than those in the control group (<0.05). After treatment, the MBI scores were increased compared with those before treatment in both groups (<0.01), the MBI score in the experimental group was higher than that in the control group (<0.05). The total effective rate in the experimental group was 86.7% (26/30), which was higher than 66.7% (20/30) in the control group (<0.05). The incidence of adverse events in the experimental group was 6.7% (2/30), which was lower than 13.3% (4/30) in the control group (<0.05).
Acupuncture based on the "head " theory combined with endovascular intervention in treating IS has good efficacy, improves neurological function, and enhances daily living ability.
观察基于“头部”理论的针刺联合血管内介入治疗缺血性脑卒中(IS)的临床疗效。
将66例IS患者随机分为试验组(33例,脱落3例)和对照组(33例,脱落3例)。对照组接受血管内介入治疗。试验组在对照组治疗的基础上,于术后第2天开始采用基于“头部”理论的针刺治疗,选取百会(GV20)及双侧风池(GB20)、天柱(BL10)等穴位,每日1次,每周6次,共2周。观察两组治疗前后美国国立卫生研究院卒中量表(NIHSS)评分、改良Barthel指数(MBI)评分及改良Rankin量表(mRS)评分,评价临床疗效及安全性。
治疗后,两组NIHSS及mRS评分均较治疗前降低(<0.01),试验组NIHSS及mRS评分低于对照组(<0.05)。治疗后,两组MBI评分均较治疗前升高(<0.01),试验组MBI评分高于对照组(<0.05)。试验组总有效率为86.7%(26/30),高于对照组的66.